[
    [
        {
            "time": "",
            "original_text": "华东医药：抗肿瘤产品“伊布替尼胶囊”正小试研究",
            "features": {
                "keywords": [
                    "华东医药",
                    "抗肿瘤",
                    "伊布替尼胶囊",
                    "小试研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：抗肿瘤产品“伊布替尼胶囊”正小试研究",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华东医药：门冬胰岛素和德谷胰岛素计划2021年申报并进入临床阶段",
            "features": {
                "keywords": [
                    "华东医药",
                    "门冬胰岛素",
                    "德谷胰岛素",
                    "2021年",
                    "申报",
                    "临床阶段"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华东医药：门冬胰岛素和德谷胰岛素计划2021年申报并进入临床阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "华东医药：制定明确的研发发展战略力争实现2025年创新业务板块占整体工业营收30%的阶段性目标",
            "features": {
                "keywords": [
                    "华东医药",
                    "研发发展战略",
                    "2025年",
                    "创新业务板块",
                    "工业营收",
                    "30%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药：制定明确的研发发展战略力争实现2025年创新业务板块占整体工业营收30%的阶段性目标",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]